Relmada Therapeutics (STU:4E2) Other Long Term Assets : €0.02 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Relmada Therapeutics Other Long Term Assets?

Relmada Therapeutics's other long-term assets for the quarter that ended in Mar. 2025 was €0.02 Mil.

Relmada Therapeutics's quarterly other long-term assets increased from Sep. 2024 (€0.02 Mil) to Dec. 2024 (€0.02 Mil) but then stayed the same from Dec. 2024 (€0.02 Mil) to Mar. 2025 (€0.02 Mil).

Relmada Therapeutics's annual other long-term assets increased from Dec. 2022 (€0.03 Mil) to Dec. 2023 (€0.04 Mil) but then declined from Dec. 2023 (€0.04 Mil) to Dec. 2024 (€0.02 Mil).

Relmada Therapeutics Other Long Term Assets Historical Data

The historical data trend for Relmada Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relmada Therapeutics Other Long Term Assets Chart

Relmada Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

0.09

0.03

0.04

0.02

Relmada Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															0.04	0.05	0.02	0.02	0.02

Relmada Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Relmada Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relmada Therapeutics Inc (STU:4E2) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

RLMD:USA

Address

2222 Ponce de Leon Boulevard, Floor 3, Coral Gables, FL, USA, 33134

Website

https://www.relmada.com

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Relmada Therapeutics Headlines

No Headlines